Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $105
Merit Medical Systems Analyst Ratings
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Raises Target Price to $92
Merit Medical Systems: Hold Rating Maintained Amid Balanced Prospects and Premium Valuation
Buy Rating Affirmed for Merit Medical Systems on Strong Q2 Performance and Promising Growth Trajectory
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $100
Buy Rating Affirmed for Merit Medical Systems on Strong Q2 Performance and Upbeat Financial Outlook
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $125
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $100
Merit Medical Systems (MMSI) Gets a Buy From Piper Sandler
Merit Medical Systems Analyst Ratings
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $94
Buy Rating Reaffirmed for Merit Medical Systems Amid Strong Financial Performance and Growth Potential
WAVE Trial Anticipation and FDA Clearance Timeline Justify Hold Rating for Merit Medical Systems
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $97
What 9 Analyst Ratings Have To Say About Merit Medical Systems
Merit Medical Systems Analyst Ratings
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
Merit Medical Systems Poised for Growth: Operational Efficiency and Strategic Product Developments Fuel Buy Rating
Hold Rating on Merit Medical Systems Amid Mixed Financial Impact of EsophyX Z+ Acquisition
No Data